Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
SGLT2i Use for HF Rises in the US, But Not in All Hospitals
TOPLINE: The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in US patients hospitalized with heart failure (HF) and a left ventricular ejection fraction > 40% increased substantially within 2 years after evidence from a clinical trial demonstrated benefits of the…
English